drugset / Trial / NCT00640588
Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine
RandomizedSingle-groupOpen-labelOther
Summary
This study will explore HBV kinetics in CHB patients during the first 24 weeks of treatment with telbivudine
Timeline
- Start
- 2008-03
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adefovir | Unknown | 10 mg | Oral |
| Subject | Telbivudine | Small molecule | 600 mg | Oral |